查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2028 年膿毒症診斷市場預測——COVID-19 的影響和按產品、技術、方法、測試類型、病原體和最終用戶進行的全球分析
市場調查報告書
商品編碼
1187265

2028 年膿毒症診斷市場預測——COVID-19 的影響和按產品、技術、方法、測試類型、病原體和最終用戶進行的全球分析

Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Technology, Method, Test Type, Pathogen, and End User
出版日期: | 出版商: The Insight Partners | 英文 267 Pages | 商品交期: 1-5個工作天內

價格

全球敗血症診斷市場預計將從 2021 年的 6.6183 億美元增長到 2028 年的 12.2652 億美元，從 2021 年到 2028 年的複合年增長率為 9.2%。我來了。 由於院內感染增加導致膿毒症發病率上升以及對快速診斷測試的需求不斷增長導致產品發布增加等因素正在推動膿毒症診斷市場的整體增長。 然而，缺乏熟練的專業人員正在阻礙敗血症診斷市場的增長。

敗血症是人體對感染的極端反應。 膿毒症是一種嚴重的臨床病症，可能由其他感染引起，包括 COVID-19 和流感等病毒感染。 這是危及生命的醫療緊急情況。 早期發現和特定的臨床干預對於改善膿毒症患者的預後至關重要。 細菌性敗血症涉及一系列反應，包括細胞缺氧、參與消除細菌及其顆粒的免疫複合物失活，以及進展為多器官衰竭。 許多醫生認為膿毒症是一種三階段綜合症，從膿毒症開始，然後是嚴重的膿毒症，然後是感染性休克，被認為是醫療急症。 敗血症的特徵是高死亡率和發病率。 敗血症診斷學是診斷敗血症的研究，敗血症是一種嚴重的臨床病症，通常由原發性細菌感染或不太常見的真菌和/或病毒感染引起。 根據國家生物技術信息中心2019年2月發表的一篇論文，敗血症的死亡率為25%至30%。

許多針對敗血症的診斷測試非常耗時，最多可能需要 72 小時才能出結果。 在所有疾病的分子診斷時代，對敗血症快速診斷檢測的需求越來越大。 因此，該行業的許多主要參與者都專注於開發創新的敗血症快速診斷測試。 例如，2020 年 9 月，總部位於巴塞羅那的 Loop Diagnostics 推出了即時診斷平台。 該平台取代了傳統的血培養分析方法，可快速提供結果。 基於血液的標記物還可以識別細菌感染，並在兩小時內提供檢測結果，準確率為 99%。 此外，2020年5月，Beckman在美國推出了具有早期敗血症指標的新型血液學分析儀DxH 690T。

此外，領先的公司已經開發出具有成本效益的診斷測試，以克服與診斷敗血症相關的所有挑戰。 例如，分子診斷先驅 Inflammatix 發布了一個健康經濟學模型，表明與標準方法相比，使用其 HostDxTM Sepsis 測試具有成本效益。 該測試是在疑似急性呼吸道感染 (ARTI) 的急診科患者中進行的。 這項研究於 2020 年 4 月發表在《衛生經濟學與成果研究雜誌》上。 該模型讓醫院臨床醫生了解廣泛採用 HostDx Sepsis 測試的潛在臨床和經濟效益。

此外，近年來對敗血症快速診斷的需求不斷增長，刺激了各大公司的研究活動。 膿毒症診斷領域的現有企業和初創企業都得到了政府和研究機構的大力支持。 例如，2020 年 4 月，Cytovale Inc. 與生物醫學高級研究與發展局 (BARDA) 合作，對包括 COVID-19 在內的呼吸道感染患者進行敗血症診斷。 該研究估計耗資 590 萬美元，其中 BARDA 出資約 383 萬美元。 因此，在預測期內，有效療法的推出和正在進行的臨床試驗將為膿毒症診斷市場提供有利可圖的機會。

全球敗血症診斷市場根據產品、技術、方法、測試類型、病原體和最終用戶進行細分。 基於產品，膿毒症診斷市場分為儀器、試劑和化驗、血液培養基和軟件。 據估計，血培養液部分將在 2021-2028 年佔據最大的市場份額。 根據《臨床微生物學家學會雜誌》的報導，血培養有助於確定膿毒症的病原體，適當選擇經驗性和特異性抗生素，並指導進一步調查以確定感染病灶。它仍然是最重要的方法之一膿毒症管理的重要調查，因為它能夠 建議對所有膿毒症患者進行血培養。 血液培養系統的自動化使得能夠在盡可能短的時間內收集到最大數量的病原體，從而改善患者管理並挽救生命。 強烈推薦這種方法，因為它在膿毒症患者的診斷檢查中揭示了最高水平的證據。 上述因素支持血培養液部分的市場增長，並最終推動敗血症診斷市場的增長。

預計在預測期內，軟件部分將在敗血症診斷市場實現最高的複合年增長率。 一些參與全球敗血症診斷市場的頂級公司不斷推出各種軟件，以保持在市場的前沿。 例如，Mobile Technologies 發布了 Nerve center Software，它在敗血症和其他危及患者生命的疾病的早期檢測中發揮著關鍵作用。 新軟件使用生命體徵和病理結果自動進行膿毒症的早期診斷，如果發現膿毒症風險，可以立即通過移動設備向適當的醫生和護士發出警報。

在編寫全球敗血症診斷市場報告時，參考了主要和次要來源，包括世界衛生組織 (WHO)、疾病控制和預防中心 (CDC)、國家醫學圖書館和國家生物技術中心信息 (NCBI)。

內容

第一章介紹

  • 調查範圍
  • Insight Partners 研究報告指南
  • 市場細分
    • 全球膿毒症診斷市場 - 按產品分類
    • 全球膿毒症診斷市場 - 按技術分類
    • 全球膿毒症診斷市場 - 按方法
    • 全球膿毒症診斷市場——按測試類型
    • 膿毒症診斷的全球市場（按病原體分類）
    • 全球膿毒症診斷市場——按最終用戶分類
    • 全球膿毒症診斷市場 - 按地區

第二章重點

第三章研究方法論

  • 範圍
  • 二次調查
  • 初步調查

第4章膿毒症診斷試劑市場-市場概況

  • 害蟲分析
    • 北美 PEST 分析
    • 歐洲 PEST 分析
    • 亞太地區 PEST 分析
    • 中東和非洲 PEST 分析
    • 拉丁美洲 PEST 分析
  • 專家意見

第 5 章膿毒症診斷市場 - 主要市場動態

  • 市場驅動力
    • 因院內感染增加而導致敗血症的高發病率
    • 對快速診斷測試的需求不斷增加，產品發布也越來越多
  • 市場製約因素
    • 缺乏熟練的專業人員
  • 市場機會
    • 增加對敗血症診斷研究的資助和支持
  • 未來趨勢
    • 膿毒症診斷技術不斷進步
  • 影響分析

第 6 章膿毒症診斷市場 - 全球分析

  • 膿毒症診斷全球市場收入預測和分析
    • 全球敗血症診斷市場收入預測和分析
    • 主要參與者的市場定位
    • 全球敗血症診斷市場 - 市場潛力分析，按地區
  • 比較公司分析
    • 增長戰略分析
    • 主要參與者的表現
      • 生物梅裡埃
      • 丹納赫
    • 敗血症診斷市場份額分析

第 7 章：膿毒症診斷全球市場收入和到 2028 年的預測 – 按產品分類

  • 全球敗血症診斷市場，按產品劃分，2021 年和 2028 年 (%)
  • 設備
  • 試劑和化驗
  • 血液培養基
  • 軟件

第 8 章膿毒症診斷市場收益和到 2028 年的預測（技術版）

  • 按技術劃分的膿毒症診斷試劑全球市場份額 - 2021 年和 2028 年 (%)
  • 分子生物學診斷方法
      • 聚合□鏈反應
      • 多□核酸-熒光原位雜交
      • 基於綜合症小組的檢查
      • 微陣列
  • 流式細胞儀
    • 實時細胞分析
      • 基於 TaqMan 的多重 RT PCR 和血培養
      • Magicplex(TM) 敗血症實時測試 - 在意大利都靈 Regina Margherita 兒童醫院進行的案例研究
      • 敗血症診斷解決方案提供商
      • 通過實時 PCR 診斷膿毒症
      • 新一代測序的新方法以及技術進步和創新
      • 通過阻抗測量進行實時細胞分析
  • 微流體
  • 免疫測定
  • 生物標誌物
    • 代謝組學
      • 膿毒症的代謝組概況
      • 代謝組學在敗血症診斷中的傳播和應用
      • 通過代謝組分析早期預測敗血症
      • 組學在膿毒症診斷和治療中的未來作用
      • 敗血症生物標誌物和診斷工具
      • 代謝組學和蛋白□□質組學在敗血症中的作用
      • 尋找預測急性腎功能衰竭預後的小分子生物標誌物的可能性
      • 代謝組學在敗血症診斷中的最新應用
      • 線粒體功能中的代謝組學
      • 代謝組學在線粒體醫學診斷中的巨大潛力
  • 微生物學

第 9 章膿毒症診斷市場收入和到 2028 年的預測 - 方法論

  • 按方法劃分的膿毒症診斷試劑全球市場份額 - 2021 年和 2028 年 (%)
  • 自動診斷
  • 常規診斷方法

第 10 章膿毒症診斷市場收入和到 2028 年的預測（按測試類型）

  • 全球敗血症診斷試劑市場：按測試類型劃分的份額 - 2021 年和 2028 年 (%)
  • 即時檢測
  • 實驗室測試

第 11 章敗血症診斷市場收益和到 2028 年的預測 - 病原體

  • 2021 年和 2028 年按病原體劃分的膿毒症診斷全球市場份額 (%)
  • 細菌性敗血症
  • 黴菌性敗血症
  • 其他

第 12 章膿毒症診斷市場收益和到 2028 年的預測（最終用戶版）

  • 敗血症診斷試劑全球最終用戶市場份額 - 2021 年和 2028 年 (%)
  • 醫院
  • 病理學和參考實驗室
  • 其他

第 13 章全球敗血症診斷市場收入和到 2028 年的預測 - 區域分析

  • 北美
    • 生物標誌物
    • 流式細胞儀
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 中東和非洲
    • 阿聯酋
    • 沙特阿拉伯
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
      • 巴西
Product Code: TIPHE100001391

The global sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028. Factors such as the rising incidence of sepsis due to increasing nosocomial infections and growing demand for rapid diagnostic tests leading to increasing product launches drive the overall growth of the sepsis diagnostics market. However, the lack of skilled professionals hampers the sepsis diagnostics market growth.

Sepsis is the body's extreme response to an infection. Sepsis is a serious clinical condition that can be a result of other infections, including viral infections, such as COVID-19 or influenza. It is a life-threatening medical emergency. Early detection and specific clinical intervention are crucial for improving the outcome of patients suffering from sepsis. Sepsis caused by bacteria involves cascade of reactions, such as lack of oxygen supply to cells and inactivation of immune complexes involved in the clearance of bacteria and its particles, which progresses to multiple organ failure. Sepsis is considered as a three staged syndrome by many physicians that starts with sepsis, leading to severe sepsis, and results in septic shock, which is considered as a medical emergency. Sepsis has a high mortality and morbidity rate. Sepsis diagnostics is the study of diagnosis of sepsis, which is a serious clinical condition that generally results from primary bacterial infection or, less frequently, from a fungal and/or viral infection. According to an article published by the National Center for Biotechnology Information in February 2019, the mortality rate of sepsis is 25 % to 30 %.

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. As a result, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. For instance, in September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform replaces the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. Additionally, in May 2020, Beckman Coulter launched its new DxH 690T hematology analyzer with early sepsis indicators in the US.

Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. For instance, Inflammatix, a pioneering molecular diagnostics company, published a health economic model that shows the use of the company's HostDxTM Sepsis test is cost-effective as compare to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in Emergency Departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test.

Furthermore, the rising need for rapid diagnostics for sepsis fueled the research activities among key players in recent years. Both the existing players and the start-ups in sepsis diagnostics are well supported financially by government and research organizations. For instance, in April 2020, Cytovale Inc. partnered with the Biomedical Advanced Research and Development Authority (BARDA) for sepsis diagnosis in patients with respiratory infections, including COVID-19. The research was estimated to stand at US$ 5.9 million, with a contribution of approximately US$ 3.83 million by BARDA. Thus, the launch of effective treatments and ongoing clinical trials would provide lucrative opportunities for the sepsis diagnostics market during the forecast period.

The global sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, and end user. Based on product, the sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment is estimated to account for the largest market share during 2021-2028. According to the Journal of the Academy of Clinical Microbiologists report, blood culture media remains one of the most critical investigations in the sepsis management as it allows identification of the responsible organism for sepsis, appropriate choice of empirical and specific antibiotics, and points toward further investigations for identifying the focus on infection. A blood culture media is recommended for all septic patients. Automation in the blood culture system has enabled maximum yield of pathogens in the shortest possible time to improve patient management and save lives. The method is highly recommended as it reveals one of the highest levels of evidence in the diagnostic workup of a sepsis patient. Such aforementioned factors support the market growth for the blood culture media segment and ultimately fuel the growth of sepsis diagnostics market.

The software segment is expected to register the highest CAGR for the overall sepsis diagnostics market during the forecast period. Several top players involved in the global sepsis diagnostics market continuously launch different software to stay forefront in the market. For instance, Mobile Technology announced the launch of Nerve center Software that play an important role in early detection of sepsis and other life-threatening conditions among patients. The new software uses vital signs and pathology results for automating the early diagnosis of sepsis and then ensures that the appropriate doctors and nurses are immediately alerted on their mobile devices when a risk of sepsis has been identified.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Library of Medicine, and National Center for Biotechnology Information (NCBI) are among the primary and secondary sources referred to while preparing the report on the global sepsis diagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the sepsis diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Sepsis Diagnostics Market - By Product
    • 1.3.2 Global Sepsis Diagnostics Market - By Technology
    • 1.3.3 Global Sepsis Diagnostics Market - By Method
    • 1.3.4 Global Sepsis Diagnostics Market - By Test Type
    • 1.3.5 Global Sepsis Diagnostics Market - By Pathogen
    • 1.3.6 Global Sepsis Diagnostics Market - By End User
    • 1.3.7 Global Sepsis Diagnostics Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Sepsis Diagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis
  • 4.3 Experts Opinion

5. Sepsis Diagnostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
    • 5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
  • 5.2 Market Restraints
    • 5.2.1 Lack of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
  • 5.4 Future Trends
    • 5.4.1 Rising Technological Advancements in Sepsis Diagnosis
  • 5.5 Impact Analysis

6. Sepsis Diagnostics Market- Global Analysis

  • 6.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
    • 6.1.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
    • 6.1.2 Market Positioning of Key Players
    • 6.1.3 Global Sepsis Diagnostics market - Market Potential Analysis, By Region
  • 6.2 Comparative Company Analysis
    • 6.2.1 Growth Strategy Analysis
    • 6.2.2 Performance of Key Players
      • 6.2.2.1 BioMerieux, Inc.
      • 6.2.2.2 Danaher
    • 6.2.3 Market Share Analysis of Sepsis Diagnostics Market

7. Global Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product

  • 7.1 Overview
  • 7.2 Global Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
  • 7.3 Instruments
    • 7.3.1 Overview
    • 7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.4 Reagents and Assays
    • 7.4.1 Overview
    • 7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.5 Blood Culture Media
    • 7.5.1 Overview
    • 7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.6 Software
    • 7.6.1 Overview
    • 7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology

  • 8.1 Overview
  • 8.2 Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
  • 8.3 Molecular Diagnostics
    • 8.3.1 Overview
    • 8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.1 Polymerase Chain Reaction
        • 8.3.2.1.1 Overview
        • 8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
        • 8.3.2.2.1 Overview
        • 8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.3 Syndromic Panel-Based Testing
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.4 Microarrays
        • 8.3.2.4.1 Overview
        • 8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Flow Cytometry
    • 8.4.1 Overview
    • 8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Real-Time Cell Analysis
      • 8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
        • 8.4.3.1.1 Characteristics of TaqMan Assays
      • 8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) - Case Study
        • 8.4.3.2.1 Abstract
        • 8.4.3.2.2 Conclusion:
      • 8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
      • 8.4.3.4 Sepsis diagnosis by real-time PCR
      • 8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
      • 8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
    • 8.4.4 Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Microfluidics
    • 8.5.1 Overview
    • 8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Immunoassay
    • 8.6.1 Overview
    • 8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Biomarkers
    • 8.7.1 Overview
    • 8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
    • 8.7.3 Metabolomics
      • 8.7.3.1 Metabolite Profile in Sepsis
      • 8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
      • 8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
      • 8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
        • 8.7.3.4.1 Genomics
        • 8.7.3.4.2 Proteomics
      • 8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
      • 8.7.3.6 Role Metabolomics and Proteomics in Sepsis
      • 8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
      • 8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
      • 8.7.3.9 Metabolics in Mitochondrial Function
      • 8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
    • 8.7.4 Metabolomics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Microbiology
    • 8.8.1 Overview
    • 8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method

  • 9.1 Overview
  • 9.2 Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
  • 9.3 Automated Diagnostics
    • 9.3.1 Overview
    • 9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Conventional Diagnostics
    • 9.4.1 Overview
    • 9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type

  • 10.1 Overview
  • 10.2 Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
  • 10.3 Point-of-Care Tests
    • 10.3.1 Overview
    • 10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Laboratory Tests
    • 10.4.1 Overview
    • 10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen

  • 11.1 Overview
  • 11.2 Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
  • 11.3 Bacterial Sepsis
    • 11.3.1 Overview
    • 11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Fungal Sepsis
    • 11.4.1 Overview
    • 11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User

  • 12.1 Overview
  • 12.2 Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
  • 12.3 Hospitals
    • 12.3.1 Overview
    • 12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 12.4 Pathology and Reference Laboratories
    • 12.4.1 Overview
    • 12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 12.5 Others
    • 12.5.1 Overview
    • 12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Global Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 13.1 North America: Sepsis Diagnostics Market
    • 13.1.1 Overview
    • 13.1.2 North America: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 13.1.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    • 13.1.4 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.1.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.1.4.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    • 13.1.5 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    • 13.1.6 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    • 13.1.7 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    • 13.1.8 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
    • 13.1.9 North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
      • 13.1.9.1 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.1.1 Overview
        • 13.1.9.1.2 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.1.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.1.9.1.4 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.1.9.1.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.1.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.1.9.1.4.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.1.9.1.5 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.1.9.1.6 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.1.9.1.7 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.1.9.1.8 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 13.1.9.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.2.1 Overview
        • 13.1.9.2.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.2.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.1.9.2.4 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.1.9.2.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.1.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.1.9.2.4.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.1.9.2.5 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.1.9.2.6 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.1.9.2.7 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.1.9.2.8 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 13.1.9.3 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.3.1 Overview
        • 13.1.9.3.2 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.9.3.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.1.9.3.4 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.1.9.3.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.1.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.1.9.3.4.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.1.9.3.5 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.1.9.3.6 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.1.9.3.7 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.1.9.3.8 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  • 13.2 Europe: Sepsis Diagnostics Market
    • 13.2.1 Overview
    • 13.2.2 Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.3 Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.4 Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
      • 13.2.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.2.4.3 Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    • 13.2.5 Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.6 Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.7 Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.8 Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 13.2.9 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
      • 13.2.9.1 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.1 Overview
        • 13.2.9.1.2 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.3 Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.4 Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.1.4.3 Germany: Sepsis Diagnostics Market, by Molecular diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.5 Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.6 Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.7 Germany: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.1.8 Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.1 Overview
        • 13.2.9.2.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.3 France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.4 France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.2.4.3 France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.5 France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.6 France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.7 France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.2.8 France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.3 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.1 Overview
        • 13.2.9.3.2 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.3 UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.4 UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.3.4.3 UK: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.5 UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.6 UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.7 UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.3.8 UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.4 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.1 Overview
        • 13.2.9.4.2 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.3 Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.4 Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.4.4.3 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.5 Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.6 Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.7 Italy: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.4.8 Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.5 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.1 Overview
        • 13.2.9.5.2 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.3 Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.4 Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.5.4.3 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.5 Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.6 Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.7 Spain: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.5.8 Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.2.9.6 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.1 Overview
        • 13.2.9.6.2 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.2.9.6.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.2.9.6.4.3 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.2.9.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 13.3 Asia Pacific: Sepsis Diagnostics Market
    • 13.3.1 Overview
    • 13.3.2 Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    • 13.3.3 Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    • 13.3.4 Asia Pacific: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
      • 13.3.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.3.4.3 Asia Pacific Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    • 13.3.5 Asia Pacific: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
    • 13.3.6 Asia Pacific: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
    • 13.3.7 Asia Pacific: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
    • 13.3.8 Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
    • 13.3.9 Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
      • 13.3.9.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.1.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.1.2 China: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.1.3 China: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
        • 13.3.9.1.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.1.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.1.3.3 China Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.1.4 China: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
        • 13.3.9.1.5 China: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
        • 13.3.9.1.6 China: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
        • 13.3.9.1.7 China: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.2 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.2.1 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.2.2 Japan: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.2.3 Japan: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.2.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.2.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.2.3.3 Japan Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.2.4 Japan: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.2.5 Japan: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.2.6 Japan: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.2.7 Japan: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.3 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.3.1 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.3.2 India: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.3.3 India: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.3.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.3.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.3.3.3 India Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.3.4 India: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.3.5 India: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.3.6 India: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.3.7 India: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.4 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.4.1 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.4.2 Australia: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.4.3 Australia: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.4.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.4.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.4.3.3 Australia Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.4.4 Australia: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.4.5 Australia: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.4.6 Australia: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.4.7 Australia: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.5 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.5.1 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.5.2 South Korea: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.5.3 South Korea: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.5.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.5.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.5.3.3 South Korea Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.5.4 South Korea: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.5.5 South Korea: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.5.6 South Korea: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.5.7 South Korea: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
      • 13.3.9.6 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.6.1 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.6.2 Rest of Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
        • 13.3.9.6.3 Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
        • 13.3.9.6.3.1 Biomarkers: Metabolomics 2019-2028
        • 13.3.9.6.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.3.9.6.3.3 Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
        • 13.3.9.6.4 Rest of Asia Pacific: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
        • 13.3.9.6.5 Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
        • 13.3.9.6.6 Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
        • 13.3.9.6.7 Rest of Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  • 13.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts To 2028
    • 13.4.1 Overview
    • 13.4.2 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    • 13.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    • 13.4.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.4.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.4.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    • 13.4.5 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    • 13.4.6 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    • 13.4.7 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    • 13.4.8 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 13.4.9 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
      • 13.4.9.1 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.1.1 Overview
        • 13.4.9.1.2 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.1.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.4.9.1.4 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.4.9.1.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.4.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.4.9.1.4.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.4.9.1.5 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.4.9.1.6 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.4.9.1.7 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.4.9.1.8 UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 13.4.9.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.2.1 Overview
        • 13.4.9.2.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.2.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.4.9.2.4 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.4.9.2.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.4.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.4.9.2.4.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.4.9.2.5 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.4.9.2.6 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.4.9.2.7 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.4.9.2.8 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 13.4.9.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.3.1 Overview
        • 13.4.9.3.2 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.3.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.4.9.3.4 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.4.9.3.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.4.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.4.9.3.4.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.4.9.3.5 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.4.9.3.6 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.4.9.3.7 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.4.9.3.8 South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 13.4.9.4 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.4.1 Overview
        • 13.4.9.4.2 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.4.9.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
        • 13.4.9.4.4 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 13.4.9.4.4.1 Biomarkers: Metabolomics 2019-2028
        • 13.4.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
        • 13.4.9.4.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
        • 13.4.9.4.5 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
        • 13.4.9.4.6 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
        • 13.4.9.4.7 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
        • 13.4.9.4.8 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • 13.5 South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028
    • 13.5.1 Overview
    • 13.5.2 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    • 13.5.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    • 13.5.4 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
      • 13.5.4.1 Biomarkers: Metabolomics 2019-2028
      • 13.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
      • 13.5.4.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    • 13.5.5 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    • 13.5.6 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    • 13.5.7 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    • 13.5.8 South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 13.5.9 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
      • 13.5.9.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.5.9.1.1 Overview
        • 13.5.9.1.2 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
        • 13.5.9.1.3 Brazil: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
    • 13.5.9

List Of Tables

  • Table 1. New next-generation sequencing techniques by Company
  • Table 2. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 3. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 4. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 5. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 6. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 7. North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 8. North America Sepsis Diagnostics Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 10. US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 11. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 12. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 13. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 14. US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 15. US Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 16. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 17. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 18. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 19. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 20. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 21. Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 22. Canada Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 23. Mexico Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 24. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 25. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 26. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 27. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 28. Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 29. Mexico Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 30. Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Europe: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Europe: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Germany: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Germany: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 46. France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 53. UK: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Italy: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Italy: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Spain: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Spain: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Asia Pacific: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 80. Asia Pacific: Sepsis Diagnostics Market, by Technology- Revenue and forecast to 2028 (USD Million)
  • Table 81. Asia Pacific: Sepsis Diagnostics Market, by Method- Revenue and forecast to 2028 (USD Million)
  • Table 82. Asia Pacific: Sepsis Diagnostics Market, by Test Type- Revenue and forecast to 2028 (USD Million)
  • Table 83. Asia Pacific: Sepsis Diagnostics Market, by Pathogen - Revenue and forecast to 2028 (USD Million)
  • Table 84. Asia Pacific: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 85. China: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 86. China: Sepsis Diagnostics Market, by Technology- Revenue and forecast to 2028 (USD Million)
  • Table 87. China: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and forecast to 2028 (USD Million)
  • Table 88. China: Sepsis Diagnostics Market, by Method- Revenue and forecast to 2028 (USD Million)
  • Table 89. China: Sepsis Diagnostics Market, by Test Type- Revenue and forecast to 2028 (USD Million)
  • Table 90. China: Sepsis Diagnostics Market, by Pathogen - Revenue and forecast to 2028 (USD Million)
  • Table 91. China: Sepsis Diagnostics Market, By End User- Revenue and Forecast to 2028 (USD Million)
  • Table 92. Japan: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 93. Japan: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 94. Japan: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 95. Japan: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
  • Table 96. Japan: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 97. Japan: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
  • Table 98. Japan: Sepsis Diagnostics Market, By End User- Revenue and Forecast to 2028 (USD Million)
  • Table 99. India: Sepsis Diagnostics Market, By Product- Revenue and Forecast to 2028(USD Million)
  • Table 100. India: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 101. India: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 102. India: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
  • Table 103. India: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 104. India: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
  • Table 105. India: Sepsis Diagnostics Market, By End User- Revenue and Forecast to 2028 (USD Million)
  • Table 106. Australia: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 107. Australia: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 108. Australia: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 109. Australia: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
  • Table 110. Australia: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 111. Australia: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
  • Table 112. Australia: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 113. South Korea: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 114. South Korea: Sepsis Diagnostics Market, By Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 115. South Korea: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 116. South Korea: Sepsis Diagnostics Market, By Method - Revenue and Forecast to 2028 (USD Million)
  • Table 117. South Korea: Sepsis Diagnostics Market, By Test Type - Revenue and Forecast to 2028 (USD Million)
  • Table 118. South Korea: Sepsis Diagnostics Market, By Pathogen - Revenue and Forecast to 2028 (USD Million)
  • Table 119. South Korea: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 120. Rest of Asia Pacific: Sepsis Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
  • Table 121. Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology- Revenue and Forecast to 2028 (USD Million)
  • Table 122. Rest of Asia Pacific: Sepsis Diagnostics Market, By Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
  • Table 123. Rest of Asia Pacific: Sepsis Diagnostics Market, By Method- Revenue and Forecast to 2028 (USD Million)
  • Table 124. Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type- Revenue and Forecast to 2028 (USD Million)
  • Table 125. Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen- Revenue and Forecast to 2028 (USD Million)
  • Table 126. Rest of Asia Pacific: Sepsis Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
  • Table 127. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million).
  • Table 128. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 129. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 130. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 131. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 132. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 133. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 134. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 135. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 136. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 137. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 138. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 139. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 140. UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 141. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 142. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 143. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 144. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 145. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 146. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 147. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 148. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 149. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 150. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 151. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 152. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 153. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 154. South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 155. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 156. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 157. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 158. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 159. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 160. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 161. Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 162. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 163. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 164. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 165. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 166. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 167. South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 168. South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 169. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 170. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 171. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 172. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 173. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 174. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 175. Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 176. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 177. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 178. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 179. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 180. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 181. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 182. Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 183. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
  • Table 184. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 185. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
  • Table 186. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
  • Table 187. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
  • Table 188. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
  • Table 189. Rest of South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 190. Recent Organic Growth Strategies in Sepsis Diagnostics Market
  • Table 191. Inorganic Developments in the Sepsis Diagnostics Market
  • Table 192. Glossary of Terms

List Of Figures

  • Figure 1. Sepsis Diagnostics Market Segmentation
  • Figure 2. Sepsis Diagnostics Market, By Region
  • Figure 3. Global Sepsis Diagnostics Market Overview
  • Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Sepsis Diagnostics Market, by Geography (US$ Million)
  • Figure 7. Global Sepsis Diagnostics Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Sepsis Diagnostics Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 16. Global Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2021 - 2028
  • Figure 18. Market Positioning of Key Players in Global Sepsis Diagnostics Market
  • Figure 19. Global Sepsis Diagnostics market - Market Potential Analysis, By Region
  • Figure 20. Global Sepsis Diagnostics market - Comparative Company Analysis
  • Figure 21. Global Sepsis Diagnostics Market - Growth Strategy Analysis
  • Figure 22. Market Share Analysis of Key Players in Global Sepsis Diagnostics Market
  • Figure 23. Global Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
  • Figure 24. Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 25. Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 26. Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 27. Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 28. Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
  • Figure 29. Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 30. Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 31. Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 32. Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 33. Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 34. Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 35. Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 36. Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 37. Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 38. Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 39. Metabolomics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 40. Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 41. Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
  • Figure 42. Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 43. Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 44. Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
  • Figure 45. Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 46. Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 47. Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
  • Figure 48. Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 49. Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 50. Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 51. Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
  • Figure 52. Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 53. Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 54. Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 55. North America: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 56. North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 58. US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. Europe: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 62. Europe: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 64. Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Asia Pacific: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 71. Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (USD Million)
  • Figure 72. Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 73. China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 74. Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 75. India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 76. Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 77. South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 78. Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 79. Middle East & Africa: Sepsis Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 80. Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 81. Middle East & Africa Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 82. UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 83. Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 84. South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 85. Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 86. South and Central America Sepsis Diagnostics Market Revenue Overview, by Key Country, 2021 (US$ Million)
  • Figure 87. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 88. South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 89. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 90. Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 91. Rest of South & Central America: Sepsis Diagnostics Market- Revenue and Forecast to 2028 (US$ Mn)
  • Figure 92. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 93. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 94. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 95. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 96. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
  • Figure 97. Growth Strategies in the Sepsis Diagnostics Market (%)